CAR-T Cell Therapy Congress USA 2018

CAR-T Cell Therapy Congress USA is organized by Kisaco Research and will be held during Mar 20 - 22, 2018 at Hilton Boston/Dedham, Dedham, Massachusetts, United States of America.

The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.

Exploring ground-breaking developments into CAR-T therapy, the event will provide the opportunity to collaborate to create a commercially viable, effective and safe therapy.

Key session topics include:
• Alternative cell constructs: TCRs, gamma delta T cells, CAR-NK & CAR-Tregs
• Commercialisation, regulation & implementation
• Safety, control & the underlying mechanisms of toxicity
• Scalability, automation & process development
• Target identification & neoantigen discovery
• Patient access & strategic considerations
• Investment & partnering workshops

Price
Academic & Not-For-Profit | 2 Day Conference: USD 799
Biopharma & Biotech | 2 Day Conference: USD 1699
Service Provider | 2 Day Conference: USD 1899
Commercialization Day Only: USD 1399


Speakers:
Venrock, Adaptimmune, Living Pharma, Dana Farber Innovations, Penn Center Innovation, ZioPharm, Merck KGaA, GSK, TCR2, Juno Therapeutics, Bellicum Pharmaceuticals, Moffitt Cancer Center, Draper Lab, Fate Therapeutics, Cellectis, Gritstone Oncology, Celyad, University of Pennsylvania, Flagship Pioneering, Children's Hospital of Philadelphia, Celgene, Massachusetts College of Pharmacy and Health, Incysus, CARMA Therapeutics, TxCell, Children's Natinal Medical Center

Additional details will be posted as soon as they are available.